Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Travel award fund launched in memory of Dr Andrew Bushell

General

TRIG and NDS have launched the Andrew Bushell Travel Bursary Fund in memory of an outstanding senior researcher and lecturer.

Dr Andrew Bushell, who sadly passed away in December 2016, was an integral part of the Wood Lab and later the Transplantation Research Immunology Group (TRIG) in the Nuffield Department of Surgical Sciences. He made many contributions to the field of transplantation and to the Wood Lab/TRIG over the 33 years that he was in the group and is fondly remembered by his friends and colleagues.

To celebrate Andrew's career and his contributions to the success of the Wood Lab/TRIG, the Andrew Bushell Travel Bursary Fund, in collaboration with his widow Ginny and his colleagues, has been set up to help provide travel bursaries for graduate students and early career researchers to attend meetings.  

Read more (Nuffield Department of Surgical Sciences website)

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

COVID winter plan: UK blueprint doesn’t go far enough – here’s a health expert’s alternative

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.